Does colon cancer cause erectile dysfunction? Colon cancer itself rarely directly causes erectile dysfunction (ED), as tumours in the colon typically do not affect the nerves, blood vessels, or hormones responsible for erections. However, men diagnosed with colorectal cancer frequently experience sexual difficulties through indirect mechanisms. Treatment-related factors—particularly surgery for rectal cancer, chemotherapy, and radiotherapy—pose the greatest risk to sexual function. Additionally, the psychological burden of a cancer diagnosis, including anxiety, depression, and altered body image, can significantly impact sexual health. Understanding these connections is essential for comprehensive cancer care and addressing sexual concerns as part of recovery.

Understanding the Link Between Colon Cancer and Erectile Dysfunction

Colon cancer itself rarely causes erectile dysfunction (ED) directly. Tumours in the colon typically do not affect the nerves, blood vessels, or hormonal systems responsible for erectile function. However, men diagnosed with colorectal cancer may experience sexual difficulties through several indirect mechanisms related to their diagnosis and treatment.

The relationship between colorectal cancer and erectile dysfunction is primarily treatment-related rather than disease-related. Surgical interventions, particularly for rectal cancer, can damage the autonomic nerves responsible for erections. Chemotherapy and radiotherapy may also contribute to sexual dysfunction through various pathways. Additionally, the psychological burden of a cancer diagnosis—including anxiety, depression, and altered body image—can significantly impact sexual desire and performance.

Rectal cancer and locally advanced pelvic disease pose a higher risk to sexual function than tumours confined to the colon. Rectal tumours and those in the rectosigmoid region lie close to the pelvic autonomic nerve plexuses that control erection and ejaculation. Advanced cancer that has spread (metastasised) to other organs may indirectly affect sexual function through general debilitation, fatigue, and pain. Tumours causing significant blood loss can lead to anaemia, which reduces energy levels and libido. Furthermore, certain cancer-related complications, such as bowel obstruction or the need for a stoma (colostomy or ileostomy), can affect a man's confidence and willingness to engage in sexual activity.

It is important to recognise that whilst colorectal cancer itself uncommonly causes erectile dysfunction directly, the overall experience of having colorectal cancer—including its treatment and emotional impact—can substantially affect sexual health. Understanding these connections helps patients and healthcare professionals address sexual concerns as part of comprehensive cancer care, rather than dismissing them as inevitable or unimportant consequences of treatment. NICE guidance on colorectal cancer (NG151) emphasises the importance of discussing potential effects on sexual function and providing ongoing information and support.

How Colorectal Cancer Treatment Can Affect Sexual Function

Surgical treatment for colorectal cancer poses the most significant risk to erectile function, particularly for tumours located in the rectum. During rectal cancer surgery (such as total mesorectal excision, anterior resection, or abdominoperineal resection), surgeons operate in close proximity to the autonomic nerve plexuses—specifically the hypogastric nerves and pelvic splanchnic nerves—which control erection, ejaculation, and bladder function. Despite nerve-sparing surgical techniques, some degree of nerve damage may be unavoidable, especially in cases requiring extensive resection or when the tumour is locally advanced. Erectile dysfunction may affect a substantial proportion of men following rectal cancer surgery, with rates varying according to surgical approach, tumour location, the extent of nerve preservation, and the surgeon's experience. Recovery of nerve function may continue for 12–24 months after surgery.

Chemotherapy can contribute to erectile dysfunction through multiple mechanisms. Certain chemotherapy agents may cause peripheral neuropathy (nerve damage) or induce fatigue and general malaise that reduces sexual interest. Oxaliplatin, commonly used in colorectal cancer treatment regimens such as FOLFOX, can cause neuropathy that may affect genital sensation. Additionally, chemotherapy-induced nausea, diarrhoea, and mucositis can make patients feel generally unwell, further diminishing libido.

Radiotherapy for rectal cancer can damage blood vessels and nerves in the pelvic region, leading to erectile dysfunction that may develop gradually over months to years following treatment. In the UK, pelvic radiotherapy is typically used as part of rectal cancer protocols. Radiation can cause fibrosis (scarring) of penile tissues and damage to the pudendal and cavernosal arteries, which supply blood to the penis. The risk is higher with higher radiation doses and when the radiation field includes more of the pelvic structures.

Stoma formation (colostomy or ileostomy), whilst not directly causing physiological erectile dysfunction, can significantly impact body image, self-confidence, and willingness to engage in sexual activity. Many men report concerns about stoma function during intimacy, odour, and partner acceptance, which can create psychological barriers to sexual expression. Specialist stoma nurses and resources from Macmillan Cancer Support and Cancer Research UK can provide valuable practical and emotional support.

Physical and Psychological Factors Contributing to Erectile Dysfunction

The development of erectile dysfunction in men with colorectal cancer typically involves a complex interplay of physical and psychological factors. Understanding both dimensions is essential for effective management and support.

Physical factors include:

• Nerve damage: Surgical injury to the autonomic nerves controlling erection is the primary physical cause, particularly following rectal cancer surgery

• Vascular compromise: Radiation therapy or surgery can damage blood vessels supplying the penis, reducing blood flow necessary for erections

• Fatigue and general debilitation: Cancer-related fatigue, anaemia, malnutrition, and the overall physical toll of treatment can diminish sexual function

• Medication side effects: Pain medications (particularly opioids), antidepressants (such as SSRIs and SNRIs), beta-blockers, thiazide diuretics, and other supportive medications may contribute to erectile difficulties

• Comorbid conditions: Many men with colorectal cancer have pre-existing conditions such as diabetes, hypertension, or cardiovascular disease, which independently increase ED risk. Erectile dysfunction can itself be an early marker of cardiovascular disease

Psychological factors are equally important and often underestimated:

• Anxiety and depression: Cancer diagnosis and treatment commonly trigger mood disorders, which are strongly associated with sexual dysfunction

• Fear and uncertainty: Concerns about cancer recurrence, mortality, and the future can preoccupy thoughts and reduce sexual desire

• Altered body image: Physical changes from surgery, weight loss, stoma formation, or hair loss can affect self-perception and confidence

• Relationship strain: The stress of cancer can impact intimate relationships, communication, and emotional connection with partners

• Performance anxiety: Previous erectile difficulties can create a cycle of anxiety that perpetuates the problem

Psychological factors may be particularly important contributors to erectile dysfunction in men who have undergone colon (rather than rectal) cancer surgery, where direct nerve damage is less likely. Your GP or specialist may assess cardiovascular risk factors and, when indicated, arrange tests such as blood glucose or HbA1c, lipid profile, blood pressure measurement, and morning total testosterone levels as part of the evaluation. Addressing both physical and psychological dimensions through a holistic, multidisciplinary approach offers the best outcomes for recovery of sexual function.

Managing Erectile Dysfunction During and After Colorectal Cancer Treatment

Effective management of erectile dysfunction in the context of colorectal cancer requires individualised assessment and a combination of treatment strategies. The approach should be tailored to the underlying causes, the patient's overall health status, relationship context, and personal preferences.

Pharmacological treatments remain first-line therapy for many men:

• Phosphodiesterase-5 (PDE5) inhibitors such as sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra) enhance erectile function by increasing blood flow to the penis. These medications require sexual stimulation to work and are effective for many men following cancer treatment, provided there is some preservation of nerve function. They may be less effective when significant nerve damage has occurred. Tadalafil may be prescribed daily at a lower dose or on-demand at a higher dose.

Important safety information: PDE5 inhibitors are contraindicated in men taking nitrates (including GTN and nicorandil) or riociguat, as the combination can cause dangerous drops in blood pressure. Use caution if you take alpha-blockers for prostate symptoms or blood pressure. These medicines should not be used if sexual activity is inadvisable due to cardiovascular conditions such as unstable angina, recent heart attack or stroke, or severe low blood pressure. Seek immediate medical attention (call 999 or go to A&E) if you experience an erection lasting more than 4 hours (priapism), sudden vision loss, or sudden hearing loss. Discuss your full medical history and all medications with your GP or specialist before starting treatment. Sildenafil 50 mg is available from pharmacies after assessment, but your cancer history and other medications warrant review by your GP or specialist.

• Vacuum erection devices (VEDs) are non-invasive mechanical aids that draw blood into the penis using negative pressure, with a constriction ring maintaining the erection. They can be particularly useful when oral medications are ineffective or contraindicated. Common issues include discomfort and bruising, but these devices are generally safe.

• Intracavernosal injections of alprostadil (a prostaglandin) directly into the penis can produce erections in men who do not respond to oral medications. Whilst effective, this approach requires training and acceptance of self-injection. Potential side effects include penile pain, priapism (requiring urgent treatment), and penile fibrosis with prolonged use.

• Intraurethral alprostadil (MUSE) involves inserting a small pellet into the urethra, though this is generally less effective than injections.

Penile rehabilitation programmes, ideally started early after surgery, are sometimes used to help preserve erectile tissue health, though the evidence base is limited and variable. These typically involve regular use of PDE5 inhibitors or VEDs to maintain oxygenation and prevent fibrosis of penile tissues. Discuss the potential benefits and limitations with your urology or andrology specialist.

Penile prosthesis (surgical implant) is a later-line option for men with refractory erectile dysfunction who have not responded to other treatments. This is available through urology or andrology services.

Psychological support and counselling are crucial components of management:

• Psychosexual therapy can address anxiety, depression, relationship issues, and performance concerns

• Couples counselling helps partners communicate about sexual concerns and adapt to changes together

• Cognitive behavioural therapy (CBT) and NHS Talking Therapies may be beneficial for managing cancer-related anxiety and depression

Lifestyle modifications support overall sexual health:

• Regular physical activity improves cardiovascular health, mood, and energy levels

• Maintaining a healthy weight and balanced diet supports recovery

• Limiting alcohol and avoiding smoking improve vascular health

• Adequate sleep and stress management enhance overall wellbeing

For men with stomas, practical advice includes emptying the pouch before intimacy, using pouch covers, experimenting with positions, and open communication with partners about concerns. Specialist stoma nurses and resources from Macmillan Cancer Support can provide valuable practical and emotional support.

Report suspected side effects: If you experience side effects from any medication, you can report them via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

When to Seek Medical Advice About Sexual Health Concerns

Sexual health is an important aspect of quality of life and should be addressed as part of comprehensive cancer care. Men experiencing erectile dysfunction or other sexual concerns during or after colorectal cancer treatment should not hesitate to seek medical advice.

Appropriate times to contact your GP or specialist include:

• Before treatment begins: Discussing potential sexual side effects with your surgical or oncology team allows for informed decision-making and may enable nerve-sparing techniques where feasible

• Persistent erectile difficulties: If erectile dysfunction continues or worsens, particularly if there is no improvement with initial measures. Recovery of nerve function after pelvic surgery may take 12–24 months, but earlier discussion is encouraged if you are distressed or wish to explore treatment options

• Psychological distress: When sexual difficulties are causing significant anxiety, depression, relationship problems, or reduced quality of life

• Lack of improvement with initial treatments: If first-line therapies such as PDE5 inhibitors are ineffective or cause unacceptable side effects

• New or worsening symptoms: Any sudden change in sexual function, pain during erection or intercourse, or other concerning symptoms

• Relationship difficulties: When sexual problems are affecting your intimate relationship and you would benefit from couples counselling

Your healthcare team can provide:

• Comprehensive assessment to identify physical and psychological contributing factors, including cardiovascular risk assessment, diabetes screening, and, when indicated, morning testosterone testing

• Referral to specialist services such as urology, andrology, psychosexual medicine, clinical psychology, or NHS Talking Therapies

• Prescription medications and guidance on their appropriate use

• Access to specialist nurses, including colorectal nurse specialists and stoma nurses who have expertise in addressing sexual concerns

• Information about support groups and charitable organisations such as Macmillan Cancer Support and Cancer Research UK offering peer support and practical resources

NICE guidance (NG151) emphasises that healthcare professionals should proactively discuss potential sexual side effects with colorectal cancer patients and provide ongoing support. However, many men feel embarrassed to raise these concerns. Remember that sexual health is a legitimate medical concern, and your healthcare team is accustomed to discussing these issues professionally and confidentially.

Seek immediate medical attention (call 999 or go to A&E) if you experience:

• An erection lasting more than 4 hours (priapism)

• Sudden vision loss or sudden hearing loss after taking erectile dysfunction medication

• Chest pain, severe dizziness, or other concerning symptoms when using erectile dysfunction medications

If erectile dysfunction is accompanied by other symptoms such as blood in urine, severe pain, or signs of infection, contact your GP promptly for assessment.

Frequently Asked Questions